Trial Profile
A retrospective study investigating the effect of somatropin (Omnitrope) in patients with Turner Syndrome (TS), growth hormone deficiency and idiopathic short stature who were receiving non-Omnitrope rhGH treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Short stature; Somatotropin deficiency; Turner's syndrome
- Focus Therapeutic Use
- 05 Dec 2015 New trial record